Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience.
Califano D, Russo D, Scognamiglio G, Losito NS, Spina A, Bello AM, Capiluongo A, Galdiero F, De Cecio R, Bevilacqua S, Gargiulo P, Marchesi E, Canevari S, Perrone F, Daniele G, De Cecco L, Mezzanzanica D, Pignata S. Califano D, et al. Cells. 2020 Apr 7;9(4):903. doi: 10.3390/cells9040903. Cells. 2020. PMID: 32272732 Free PMC article.
HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, De Simone V, Califano D, Pallante P, Botti G, Pezzullo L, Pierantoni GM, Santoro M, Fusco A. Chiappetta G, et al. Among authors: califano d. Eur J Cancer. 2008 May;44(7):1015-21. doi: 10.1016/j.ejca.2008.02.039. Epub 2008 Mar 28. Eur J Cancer. 2008. PMID: 18375116
FEZ1/LZTS1 protein expression in ovarian cancer.
Califano D, Pignata S, Pisano C, Greggi S, Laurelli G, Losito NS, Ottaiano A, Gallipoli A, Pasquinelli R, De Simone V, Cirombella R, Fusco A, Chiappetta G. Califano D, et al. J Cell Physiol. 2010 Feb;222(2):382-6. doi: 10.1002/jcp.21962. J Cell Physiol. 2010. PMID: 19885841
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Bagnoli M, Canevari S, Califano D, Losito S, Maio MD, Raspagliesi F, Carcangiu ML, Toffoli G, Cecchin E, Sorio R, Canzonieri V, Russo D, Scognamiglio G, Chiappetta G, Baldassarre G, Lorusso D, Scambia G, Zannoni GF, Savarese A, Carosi M, Scollo P, Breda E, Murgia V, Perrone F, Pignata S, De Cecco L, Mezzanzanica D; Multicentre Italian Trials in Ovarian cancer (MITO) translational group. Bagnoli M, et al. Among authors: califano d. Lancet Oncol. 2016 Aug;17(8):1137-1146. doi: 10.1016/S1470-2045(16)30108-5. Epub 2016 Jul 9. Lancet Oncol. 2016. PMID: 27402147 Free article.
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC.
Perrone F, Baldassarre G, Indraccolo S, Signoriello S, Chiappetta G, Esposito F, Ferrandina G, Franco R, Mezzanzanica D, Sonego M, Zulato E, Zannoni GF, Canzonieri V, Scambia G, Sorio R, Savarese A, Breda E, Scollo P, Ferro A, Tamberi S, Febbraro A, Natale D, Di Maio M, Califano D, Scognamiglio G, Lorusso D, Canevari S, Losito S, Gallo C, Pignata S. Perrone F, et al. Among authors: califano d. Oncotarget. 2016 Nov 8;7(45):72654-72661. doi: 10.18632/oncotarget.12056. Oncotarget. 2016. PMID: 27655643 Free PMC article. Clinical Trial.
CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.
Dall'Acqua A, Sonego M, Pellizzari I, Pellarin I, Canzonieri V, D'Andrea S, Benevol S, Sorio R, Giorda G, Califano D, Bagnoli M, Militello L, Mezzanzanica D, Chiappetta G, Armenia J, Belletti B, Schiappacassi M, Baldassarre G. Dall'Acqua A, et al. Among authors: d andrea s, califano d. EMBO Mol Med. 2017 Oct;9(10):1415-1433. doi: 10.15252/emmm.201607012. EMBO Mol Med. 2017. PMID: 28778953 Free PMC article.
92 results